Repurposing of antitumor drug candidate Quisinostat lead to novel spirocyclic antimalarial agents

doi:10.1016/j.cclet.2020.12.023

中国化学快报 ›› 2021, Vol. 32 ›› Issue (05) : 1660-1664. DOI: 10.1016/j.cclet.2020.12.023

通信

Repurposing of antitumor drug candidate Quisinostat lead to novel spirocyclic antimalarial agents

{{article.zuoZhe_CN}}

作者信息 +

Repurposing of antitumor drug candidate Quisinostat lead to novel spirocyclic antimalarial agents

{{article.zuoZhe_EN}}

Author information +

History +

本文亮点

HeighLight

摘要

Abstract

关键词

Key words

引用本文

EndNote

Ris (Procite)

Bibtex

导出引用

{{article.zuoZheCn_L}}. {{article.title_cn}}. {{journal.qiKanMingCheng_CN}}. 2021, 32(05): 1660-1664 https://doi.org/10.1016/j.cclet.2020.12.023

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2021, 32(05): 1660-1664 https://doi.org/10.1016/j.cclet.2020.12.023

参考文献

原文顺序 | 文献年度倒序 | 文中引用次数倒序

参考文献

基金

版权

PDF(2326 KB)

Accesses

Citation

Detail

段落导航

Received	Revised	Published
2020-11-01	2020-11-26	2021-05-22
Issue Date
2021-05-22

选择文件类型/文献管理软件名称

选择包含的内容

本文亮点

HeighLight

摘要

Abstract

关键词

Key words

引用本文

{{custom_sec.title}}

{{custom_sec.title}}

参考文献

参考文献

{{custom_fnGroup.title_cn}}

脚注

{{custom_ack.title_cn}}

基金

版权